ANRO · Alto Neuroscience, Inc. · Debt
$21.97
-0.23 (-1.04%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$862.15M
Shares
39.24M
Volume · Oct 23
379.26K
Avg daily vol (3M)
554.74K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Convertible debt, including current maturities | 2026-06-30 | USD 2,465,000 | 10-Q filed 2026-08-12 |
| Current operating lease liabilities | 2026-06-30 | USD 1,361,000 | 10-Q filed 2026-08-12 |
| Current portion of long-term debt | 2026-06-30 | USD 3,768,000 | 10-Q filed 2026-08-12 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 12,419,000 | 10-Q filed 2026-08-12 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 3,281,000 | 10-Q filed 2026-08-12 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1999480
CUSIP
02157Q109
13F (30d)
10 filings
10 filers
Visit website
Investor relations